tiprankstipranks
BioRestorative Therapies to Announce Phase 2 Trial Data
Company Announcements

BioRestorative Therapies to Announce Phase 2 Trial Data

Don't Miss our Black Friday Offers:

BioRestorative Therapies ( (BRTX) ) has shared an update.

BioRestorative Therapies, Inc. is set to reveal promising data from its Phase 2 clinical trial of BRTX-100 for chronic lumbar disc disease at the upcoming International Spine Research Symposium. The company will also host a webcast on November 13, 2024, to discuss these findings, review its third quarter financial results, and provide a business update, offering insights into its ongoing research and financial health.

See more insights into BRTX stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskBioRestorative Therapies Q3 2024 Financial Update
TipRanks Auto-Generated NewsdeskBioRestorative Therapies Showcases Promising Stem Cell Advances
TheFlyBioRestorative Therapies reports Phase 2 BRTX-100 clinical data
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App